Sign In
Buy MLAB
$104.38
-2.28 (-2.14%)
At Close: Jun 03, 2026
Mesa Labs (MLAB) Q4 Earnings and Revenues Miss Estimates
10:31am, Thursday, 25'th May 2023
Mesa Labs (MLAB) came out with quarterly earnings of $1.94 per share, missing the Zacks Consensus Estimate of $1.98 per share. This compares to earnings of $2.22 per share a year ago.
Mesa Laboratories: Divisional Growth, Valuations Supportive Of Hold
08:26pm, Monday, 27'th Feb 2023
In Q3, Mesa Laboratories reported mixed results throughout the P&L with soft bottom-line fundamentals. FCF growth still lumpy with contraction in divisional growth.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Tuesday, 14'th Feb 2023
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Is Mesa Labs (MLAB) a Solid Growth Stock? 3 Reasons to Think "Yes"
02:18pm, Monday, 13'th Feb 2023
Mesa Labs (MLAB) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Mesa Labs (MLAB) Tops Q3 Earnings Estimates
11:17am, Monday, 06'th Feb 2023
Mesa Labs (MLAB) delivered earnings and revenue surprises of 11.90% and 5.95%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Mesa Laboratories' (MLAB) Q3 Earnings?
02:18pm, Wednesday, 01'st Feb 2023
Continued strength in Mesa Laboratories' (MLAB) Clinical Genomics segment is expected to have driven up Q3 sales.
Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year?
11:17am, Thursday, 12'th Jan 2023
Here is how Mesa Labs (MLAB) and Cassava Sciences, Inc. (SAVA) have performed compared to their sector so far this year.
Bull of the Day: Mesa Labs (MLAB)
06:46am, Wednesday, 28'th Dec 2022
After Q2 results, EPS estimates soar 39% as revenues grow 24% on strong M&A strategies
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023
11:59am, Friday, 16'th Dec 2022
LAKEWOOD, Colo., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2023 at approximately 8:
Earnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy?
01:33pm, Wednesday, 23'rd Nov 2022
Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates
12:02pm, Thursday, 03'rd Nov 2022
Mesa Labs (MLAB) delivered earnings and revenue surprises of 107.19% and 10.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates
12:47pm, Thursday, 04'th Aug 2022
Mesa Labs (MLAB) delivered earnings and revenue surprises of -40% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates
10:33am, Tuesday, 31'st May 2022
Mesa Labs (MLAB) delivered earnings and revenue surprises of 18.09% and 6.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
RVT: 8% Dividend Yield With Upside To Valuation
04:52am, Monday, 04'th Apr 2022
RVT: 8% Dividend Yield With Upside To Valuation
Mesa Laboratories Non-GAAP EPS of $1.36 beats by $0.04, revenue of $54.69M beats by $10.22M
02:12pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $1.36 beats by $0.04.Revenue of $54.69M (+60.1% Y/Y) beats by $10.22M.
